220 related articles for article (PubMed ID: 1730031)
61. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
[TBL] [Abstract][Full Text] [Related]
62. On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogen.
Lijnen HR; Van Hoef B; Collen D
Thromb Res Suppl; 1990; 10():45-54. PubMed ID: 2107598
[TBL] [Abstract][Full Text] [Related]
63. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
[TBL] [Abstract][Full Text] [Related]
64. [Regulation with alpha-2-antiplasmin of Glu-plasminogen activation by tissue activator on fibrin].
Hrynenko TV; Zadorozhna MB; Iusova OI
Ukr Biokhim Zh (1999); 2006; 78(3):106-12. PubMed ID: 17100317
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line.
Fair DS; Plow EF
J Lab Clin Med; 1983 Mar; 101(3):372-84. PubMed ID: 6186756
[TBL] [Abstract][Full Text] [Related]
66. Synergistic fibrinolysis: The combined effects of tissue plasminogen activator and recombinant staphylokinase in vitro.
Aisina R; Mukhametova L; Varfolomeyev S
Biochim Biophys Acta; 2016 Apr; 1860(4):629-35. PubMed ID: 26723174
[TBL] [Abstract][Full Text] [Related]
67. Fibrin-mediated plasminogen activation.
Nieuwenhuizen W
Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
[TBL] [Abstract][Full Text] [Related]
68. Effects of endothelial cells on activity of staphylokinase.
Ueshima S; Okada K; Matsumoto H; Takaishi T; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):522-9. PubMed ID: 8874862
[TBL] [Abstract][Full Text] [Related]
69. A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
Hirata Y; Umemura K; Takiguchi Y; Uematsu T; Nakashima M
Blood Coagul Fibrinolysis; 1993 Aug; 4(4):569-75. PubMed ID: 7692999
[TBL] [Abstract][Full Text] [Related]
70. Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
Weitz JI; Leslie B; Hirsh J; Klement P
J Clin Invest; 1993 Apr; 91(4):1343-50. PubMed ID: 7682569
[TBL] [Abstract][Full Text] [Related]
71. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease.
Kim PY; Stewart RJ; Lipson SM; Nesheim ME
J Thromb Haemost; 2007 Jun; 5(6):1250-6. PubMed ID: 17266698
[TBL] [Abstract][Full Text] [Related]
72. Effect of staphylokinase concentration of plasminogen activation.
Arai K; Mimuro J; Madoiwa S; Matsuda M; Sako T; Sakata Y
Biochim Biophys Acta; 1995 Aug; 1245(1):69-75. PubMed ID: 7654768
[TBL] [Abstract][Full Text] [Related]
73. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.
Schlott B; Hartmann M; Gührs KH; Birch-Hirschfeld E; Gase A; Vettermann S; Collen D; Lijnen HR
Biochim Biophys Acta; 1994 Feb; 1204(2):235-42. PubMed ID: 8142464
[TBL] [Abstract][Full Text] [Related]
74. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.
Zamarron C; Lijnen HR; Collen D
J Biol Chem; 1984 Feb; 259(4):2080-3. PubMed ID: 6538196
[TBL] [Abstract][Full Text] [Related]
75. Induction of catalytic activity of plasminogen by monoclonal antibody IV-Ic in the presence of divalent metal cations and alpha2-antiplasmin.
Sokolovskaya LI; Slominskii AY; Volkov GL
Biochemistry (Mosc); 2006 Jun; 71(6):627-33. PubMed ID: 16827654
[TBL] [Abstract][Full Text] [Related]
76. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
Nilsson T; Sjöholm I; Wiman B
Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
[TBL] [Abstract][Full Text] [Related]
77. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin.
Humphries JE; Vasudevan J; Gonias SL
Arterioscler Thromb; 1993 Jan; 13(1):48-55. PubMed ID: 7678497
[TBL] [Abstract][Full Text] [Related]
78. Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.
Christensen S; Sottrup-Jensen L; Christensen U
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):97-102. PubMed ID: 7529997
[TBL] [Abstract][Full Text] [Related]
79. Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
Aoki N; Sakata Y; Ichinose A
Blood; 1983 Nov; 62(5):1118-22. PubMed ID: 6626743
[TBL] [Abstract][Full Text] [Related]
80. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
